Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance

Cardiovascular Diabetology

Volumn 5, Issue , 2006, Pages

  Schmoelzer, Isabella ^a   Wascher, Thomas C ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REPAGLINIDE; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DILATATION; ARTICLE; BLOOD SAMPLING; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG EFFECT; ENDOTHELIUM LESION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MALE; OPEN STUDY; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL;

AGED; BLOOD GLUCOSE; CARBAMATES; CROSS-OVER STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; PROSPECTIVE STUDIES; VASCULAR DISEASES;

EID: 33646556110     PISSN: 14752840     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-5-9     Document Type: Article

References (15)

1. Qiao Q, Tuomilehto, Borch-Johnson K: Postchallenge hyperglycemia is associated with premature death and macrovascular complications. Diabetologia 2003, 46(suppl.1):M17-M21.
2. The Decode Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The Lancet 1999, 354:617-621.
3. Celermajer DS: Endothelial dysfunction: does it matter? Is it reversible? JACC 1997, 30:325-333.
4. Schaechinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
5. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstemann U, Munzel T: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001, 88:14-22.
6. Kawano H, Motoyama T, Hirashima O, Nobutaka H, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H: Hyperglycemia rapidly suppresses flow- mediated endothelium-dependent vasodilatation of brachial artery. JACC 1999, 34:146-154.
7. Rudofsky G Jr, Reismann P, Schiekofer S, Petrov D, von Eynatten M, Humpert PM, Isermann B, Muller-Hoff C, Thai TP, Lichtenstein S, Bartsch U, Hamann A, Nawrath P, Bierhaus A: Reduction of postprandial hyperglycemia in patients with type 2 diabetes reduces NF-KappaB activation in PBMCs. Horm Metab Res 2004, 36:630-638.
8. Stuehlinger MC, Oka RK, Graf EE, Schmoelzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP: Endothelial dysfunction induced by hyperhomocysteinemia: role of asymmetric dimethylarginine. Circulation 2002, 105:1567-1572.
9. Balletshofer BM, Goebbel S, Rittig K, Enderle M, Schmölzer I, Wascher T, Ferenc Pap A, Westermeier T, Petzinna D, Matthaei S, Haring HU: Intensive Cholesterol Lowering Therapy with a HMG-CoA Reductase Inhibitor does not improve Nitric Oxide Dependent Endothelial Function in Type-2 - Diabetes. Exp Clin Endocrinol Diabetes 2005, 113:324-330.
10. Frick M, Neunteufl T, Schwarzacher SP, Wascher TC, Weidinger F: Flußvermittelte Vasodilatation (FMD) der Arteria brachialis: Methodik und klinischer Stellenwert. J Kardiol 2002:439-444.
11. Ceriello A: Impaired glucose tolerance and cardiovascular disease: The possible role of post-prandial hyperglycemia. Am Heart J 2004, 147:803-7.
12. Ceriello A, Cavarape A, Martinelli L, Da Ros R, Marra G, Quagliaro L, Piconi L, Assaloni R, Motz E: The post-prandiall state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabetic Medicine 2004, 21:171-175.
13. Manzella D, Grella R, Abbatecola AM, Paolisso G: Repaglinide administration improves brachial reactivity in type 2 diabetic patients. Diabetes Care 2005, 28(2):366-71.
14. Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, Panza JA: Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999, 100(8):820-5.
15. Wolever TMS, Chiasson JL, Csima A, Hunt JA, Palmason C, Ross SA, Ryan EA: Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose. Diabetes care 1998, 21:336-40.